Skip to main content
Drug bottle and Pill

Compare Ohtuvayre vs. Dupixent

Head-to-head comparisons of medication uses, side effects, warnings, and more.

Key takeaways

Ohtuvayre (ensifentrine) and Dupixent (dupilumab) are both prescription medications used to treat conditions related to inflammation. Ohtuvayre is specifically FDA-approved for chronic obstructive pulmonary disease (COPD), while Dupixent is used for a variety of inflammatory conditions, including COPD, asthma, and eczema. Ohtuvayre is a phosphodiesterase 3 and 4 inhibitor taken via inhalation twice daily using a nebulizer, whereas Dupixent is a monoclonal antibody administered as a subcutaneous injection every other week or monthly. Neither medication is available in a generic form. Ohtuvayre's common side effects include back pain and high blood pressure, while Dupixent cause injection site reactions and eye inflammation. Ohtuvayre should not be mixed with other medications in a nebulizer. Dupixent may interact with live vaccines, so you should avoid them while on this medication.

Browse medications

View All

Research prescriptions and over-the-counter medications from A to Z, compare drug prices, and start saving.